| Identification | Back Directory | [Name]
Quinoline, 2-[[4-[1-Methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]Methyl]- ,succinate salt | [CAS]
1037309-45-7 | [Synonyms]
MP-10 succinate
MP 10 succinate salt
PF-2545920 (succinate salt)
MP 10 succinate,MP10 succinate
2-((4-(1-Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline succinate
Quinoline, 2-[[4-[1-Methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]Methyl]- ,succinate salt | [Molecular Formula]
C29H26N4O5 | [MDL Number]
MFCD16038845 | [MOL File]
1037309-45-7.mol | [Molecular Weight]
510.541 |
| Hazard Information | Back Directory | [Uses]
Mardepodect succinate (PF-2545920 succinate) is a potent and specific phosphodiesterase 10A (PDE10A) inhibitor with potential activity in the treatment of schizophrenia. Mardepodect succinate has been further optimized to improve brain penetration and compound-like properties for use in schizophrenia research[1]. | [References]
[1] Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
| Company Name: |
Matrix Scientific
|
| Tel: |
803 788-9494 All other calls |
| Website: |
www.matrixscientific.com |
|